In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody

Saved in:
Bibliographic Details
Main Authors: James G. Krueger, Brian S. Kim, Stephan Weidinger, Yoko Kataoka, John T. O'Malley, Karl Yen, Cassie Van Krinks, Jose Vela
Format: Article
Language:English
Published: Medical Journals Sweden 2025-08-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/43608
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233909070430208
author James G. Krueger
Brian S. Kim
Stephan Weidinger
Yoko Kataoka
John T. O'Malley
Karl Yen
Cassie Van Krinks
Jose Vela
author_facet James G. Krueger
Brian S. Kim
Stephan Weidinger
Yoko Kataoka
John T. O'Malley
Karl Yen
Cassie Van Krinks
Jose Vela
author_sort James G. Krueger
collection DOAJ
format Article
id doaj-art-74d3e15a447e4e4c804fe05289f96712
institution Kabale University
issn 0001-5555
1651-2057
language English
publishDate 2025-08-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj-art-74d3e15a447e4e4c804fe05289f967122025-08-20T04:03:21ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572025-08-0110510.2340/actadv.v105.43608In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal AntibodyJames G. Krueger0Brian S. Kim1Stephan Weidinger2Yoko Kataoka3John T. O'Malley4Karl Yen5Cassie Van Krinks 6Jose Vela7Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USADepartment of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Dermatology, Osaka Habikino Medical Center, Habikino, JapanSanofi, Cambridge, MA, USASanofi, Rotkreuz, SwitzerlandFormerly Sanofi, Cambridge, UKSanofi, Cambridge, MA, USAhttps://medicaljournalssweden.se/actadv/article/view/43608amlitelimabatopic dermatitisOX40Lregulatory T-cellsT cellsinflammation
spellingShingle James G. Krueger
Brian S. Kim
Stephan Weidinger
Yoko Kataoka
John T. O'Malley
Karl Yen
Cassie Van Krinks
Jose Vela
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
Acta Dermato-Venereologica
amlitelimab
atopic dermatitis
OX40L
regulatory T-cells
T cells
inflammation
title In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
title_full In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
title_fullStr In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
title_full_unstemmed In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
title_short In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
title_sort in vitro evidence demonstrating the nondepleting mechanism of action of amlitelimab an ox40 ligand monoclonal antibody
topic amlitelimab
atopic dermatitis
OX40L
regulatory T-cells
T cells
inflammation
url https://medicaljournalssweden.se/actadv/article/view/43608
work_keys_str_mv AT jamesgkrueger invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT brianskim invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT stephanweidinger invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT yokokataoka invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT johntomalley invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT karlyen invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT cassievankrinks invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody
AT josevela invitroevidencedemonstratingthenondepletingmechanismofactionofamlitelimabanox40ligandmonoclonalantibody